Literature DB >> 28215067

Epidemiology and natural history of gastroesophageal reflux disease.

Edoardo Savarino1, Elisa Marabotto2, Giorgia Bodini2, Gaia Pellegatta2, Claudia Coppo2, Elisa Giambruno2, Matteo Brunacci2, Patrizia Zentilin2, Vincenzo Savarino2.   

Abstract

Gastroesophageal reflux disease (GERD) is highly prevalent in Western countries, particularly when considering its most classic symptom that is heartburn. This symptom is very frequent in the community and ranges from 10% to more than 30%, according to the various population-based studies. This disease is much more represented in Europe and USA than in Asiatic countries. It has been shown that GERD prevalence increases in parallel with the remarkable growth of obesity, as this condition is able to favor all the pathogenetic mechanisms leading to it. Current information regarding the phenotypic presentation of GERD shows that there are two main phenotypic manifestations, that are erosive reflux disease (ERD) and non-erosive reflux disease (NERD) and the latter includes the majority of patients (up to 70%). The major complication of GERD is the development of Barrett esophagus, a pre-malignant lesion potentially leading to esophageal adenocarcinoma. Data from medical literature on the natural history of this disease are scant and mainly retrospective, so the interpretation of them is very difficult. However, they seem to suggest that both NERD and mild esophagitis tend to remain as such overtime and the progression from NERD to ERD, from mild to severe ERD and from ERD to Barrett's esophagus may occur only in a small number of cases, ranging from 0% to 30%, 10-22% and 1-13%, respectively. Future studies should help us in elucidating better the real transition from one category to another and to do this, we have to exclude from the world of GERD all the functional conditions that nowadays can be easily recognized by means of impedance-pH monitoring.

Entities:  

Mesh:

Year:  2017        PMID: 28215067     DOI: 10.23736/S1121-421X.17.02383-2

Source DB:  PubMed          Journal:  Minerva Gastroenterol Dietol        ISSN: 1121-421X


  10 in total

1.  Association of Gastroesophageal Reflux With Malignancy of the Upper Aerodigestive Tract in Elderly Patients.

Authors:  Charles A Riley; Eric L Wu; Mei-Chin Hsieh; Michael J Marino; Xiao-Cheng Wu; Edward D McCoul
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-02-01       Impact factor: 6.223

2.  Impact of subspecialty training on management of laryngopharyngeal reflux: results of a worldwide survey.

Authors:  Lee M Akst; Jonathan M Bock; Jerome R Lechien; Thomas L Carroll; Jacqueline E Allen; Tareck Ayad; Necati Enver; Young-Gyu Eun; Paulo S Perazzo; Fabio Pupo Ceccon; Geraldo D Sant'Anna; Rui Imamura; Sampath Kumar Raghunandhan; Carlos M Chiesa-Estomba; Christian Calvo-Henriquez; Sven Saussez; Petros D Karkos; Marc Remacle
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-27       Impact factor: 2.503

3.  Protective Mechanisms of Liquid Formulations for Gastro-Oesophageal Reflux Disease in a Human Reconstructed Oesophageal Epithelium Model.

Authors:  Laura Ceriotti; Paolo Buratti; Enrico Stefano Corazziari; Marisa Meloni
Journal:  Med Devices (Auckl)       Date:  2022-05-18

4.  Antireflux mucosectomy band in treatment of refractory gastroesophageal reflux disease: a pilot study for safety, feasibility and symptom control.

Authors:  Laurent Monino; Jean-Michel Gonzalez; Véronique Vitton; Marc Barthet
Journal:  Endosc Int Open       Date:  2020-01-22

5.  Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease.

Authors:  Ya-Mei Zheng; Xian-Yun Chen; Jie-Yi Cai; Yu Yuan; Wen-Rui Xie; Jia-Ting Xu; Harry Hua-Xiang Xia; Min Zhang; Xing-Xiang He; Li-Hao Wu
Journal:  World J Gastroenterol       Date:  2021-02-14       Impact factor: 5.742

6.  Prevalence of Gastroesophageal Reflux Disease and Associated Risk Factors in the Eastern Region, Saudi Arabia.

Authors:  Hussain A Al Ghadeer; Zahra E Alabbad; Salwa B AlShaikh; Shaheen U Ahmed; Ali A Bu-Khamseen; Ali T Alhashem; Alaa H Alhamrani; Mohammed R AlGhadeer; Dhiyaa A Alibrahim; Bassil M Alkishi
Journal:  Cureus       Date:  2021-11-15

7.  Tandem Mass Tag Analysis of the Effect of the Anterior Cingulate Cortex in Nonerosive Reflux Disease Rats with Shugan Jiangni Hewei Granules Treatment.

Authors:  Tianzuo Wang; Jing Li; Yuebo Jia; Jiaqi Zhao; Meijun He; Guang Bai
Journal:  Comput Math Methods Med       Date:  2022-07-30       Impact factor: 2.809

Review 8.  Drugs for improving esophageal mucosa defense: where are we now and where are we going?

Authors:  Edoardo Savarino; Patrizia Zentilin; Elisa Marabotto; Gaia Pellegatta; Claudia Coppo; Matteo Brunacci; Pietro Dulbecco; Vincenzo Savarino
Journal:  Ann Gastroenterol       Date:  2017-08-17

9.  Bidirectional association between gastroesophageal reflux disease and depression: Two different nested case-control studies using a national sample cohort.

Authors:  So Young Kim; Hyung-Jong Kim; Hyun Lim; Il Gyu Kong; Miyoung Kim; Hyo Geun Choi
Journal:  Sci Rep       Date:  2018-08-06       Impact factor: 4.379

Review 10.  Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders.

Authors:  Nicola de Bortoli; Salvatore Tolone; Marzio Frazzoni; Irene Martinucci; Giulia Sgherri; Eleonora Albano; Linda Ceccarelli; Cristina Stasi; Massimo Bellini; Vincenzo Savarino; Edoardo V Savarino; Santino Marchi
Journal:  Ann Gastroenterol       Date:  2018-09-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.